# The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

> **NCT00492596** · PHASE3 · COMPLETED · sponsor: **Solace Therapeutics, Inc.** · enrollment: 166 (actual)

## Conditions studied

- Urinary Incontinence, Stress

## Interventions

- **DEVICE:** AttenueX IntraVesical System
- **PROCEDURE:** Sham Procedure

## Key facts

- **NCT ID:** NCT00492596
- **Lead sponsor:** Solace Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2014-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492596, "The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00492596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*